Lesaffre completes the full acquisition of the Italian biotechnology company Gnosis • Lesaffre Human Care
22909
post-template-default,single,single-post,postid-22909,single-format-standard,ajax_fade,page_not_loaded,,qode_popup_menu_text_scaledown,qode-child-theme-ver-1.0.0,qode-theme-ver-13.3,qode-theme-bridge,disabled_footer_top,wpb-js-composer js-comp-ver-5.4.5,vc_responsive

Lesaffre completes the full acquisition of the Italian biotechnology company Gnosis

Lesaffre completes the full acquisition of the Italian biotechnology company Gnosis

Gnosis Lesaffre

Lesaffre, a key global actor in the field of yeast and fermentation, announces the full acquisition of Gnosis, an Italian biotechnology company specialized in the development, manufacturing and sale of fermentation-derived ingredients and natural finished products for use in the pharmaceutical, nutraceutical, veterinary and cosmetic industries, three years after acquiring a majority shareholding of this company.



at fringilla massa nec velit, risus. Nullam in mattis quis dictum lectus